Fluoxetine in the Treatment of Premenstrual Dysphoria
New England Journal of MedicinePublished 8 June 1995
Meir Steiner, Susanne Steinberg, Donna E. Stewart, Diana Carter, Charlene Berger, Robert L. Reid
Citations448
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Fluoxetine at a dose of 20 or 60 mg per day was significantly superior to placebo in reducing symptoms of tension, irritability, and dysphoria, as measured by the visual-analogue scales.
Abstract
Fluoxetine is useful in the treatment of premenstrual dysphoria. Treatment with fluoxetine at a dose of 20 mg per day reduces the potential for side effects while maximizing therapeutic efficacy.
Keywords
Medicine
American Journal of Occupational TherapyDiagnostic and Statistical Manual of Mental Disorders (3rd ed. rev.) Diagnostic and Statistical Manual of Mental Disorders (3rd ed. rev.) American Psychiatric Association (1987). American Psychiatric Press, Inc., 1400 K Street, NW, Washington, DC 20005. 567 pp., $39.95 hardcover; $29.95 softcover.
5,310 Citations1988Margaret Drake
Psychological MedicineClinical applications of visual analogue scales: a critical review
2,102 Citations1988Heather M. McCormack, David Horné +1 more
Decisions concerning the choice of scoring interval, experimental design, and statistical analysis for VAS have in some instances been based on convention, assumption and convenience, highlighting the need for more comprehensive assessment of individual scales if this versatile and sensitive measurement technique is to be used to full advantage.
Archives of General PsychiatrySome Conceptual and Statistical Issues in Analysis of Longitudinal Psychiatric Data
728 Citations1993Robert D. Gibbons
A family of statistical models termed random regression models were used that provide a more realistic approach to analysis of longitudinal psychiatric data and indicated that both person-specific effects and serial correlation play major roles in the longitudinal psychiatric response process.
American Journal of PsychiatryEmergence of intense suicidal preoccupation during fluoxetine treatment
534 Citations1990Martin H. Teicher, Carol A. Glod +1 more
Six depressed patients free of recent serious suicidal ideation developed intense, violent suicidal preoccupation after 2-7 weeks of fluoxetine treatment, and none of them had ever experienced a similar state during treatment with any other psychotropic drug.
The Canadian Journal of PsychiatryAn Introduction to Multivariate Statistics
399 Citations1993David L. Streiner
There are costs associated with these benefits, such as increased complexity, decreased power, multiple ways of answering the same question, and ambiguity in the allocation of shared variance.
Archives of General PsychiatryFluoxetine in the Treatment of Bulimia Nervosa
363 Citations1992
The results indicate that fluoxetine may have a role in the treatment of bulimia and that further investigation is warranted.
DrugsFluoxetine
336 Citations1986Paul Benfield, R.C. Heel +1 more
Fluoxetine has overall therapeutic efficacy comparable with imipramine, amitriptyline and doxepin in patients with unipolar depression treated for 5 to 6 weeks, although it may be less effective than tricyclic antidepressants in relieving sleep disorders in depressed patients.
Acta Psychiatrica ScandinavicaPremenstrual tension syndrome: The development of research diagnostic criteria and new rating scales
283 Citations1980M. Steiner, Roger F. Haskett +1 more
Research diagnostic criteria for premenstrual tension syndrome (PMTS) are developed using data collected from a study of 42 women who were suffering from severe PMTS but were well at other times.
New England Journal of MedicineThe Premenstrual Syndrome
269 Citations1984Ken Muse, Nancy S. Cetel +2 more
American Journal of PsychiatryProspective assessment of menstrually related mood disorders
219 Citations1984David R. Rubinow, Peter Roy‐Byrne +3 more
In a preliminary application of this measure to 20 women with self-diagnosed premenstrual syndrome, eight had a mean depression rating during the week before menstruation that was 30% higher than During the week after cessation of menstruation.
PubMedThe side effect profile and safety of fluoxetine.
181 Citations1985Wernicke Jf
Analysis of adverse experiences leading to discontinuations suggests that this drug has very few serious side effects, and fluoxetine appears to have no epileptogenic potential except at extremely high doses and is usually well tolerated in overdoses.
American Journal of PsychiatryLate luteal phase dysphoric disorder in young women
163 Citations1990Ana Rivera-Tovar, Ellen Frank
Compared to 25 young women seeking treatment for PMS who met the same diagnostic criteria, the 10 women from the university sample reported significantly less fatigue and impaired concentration and somewhat less severe depression and overall symptoms.
Acta Psychiatrica ScandinavicaClomipramine effectively reduces premenstrual irritability and dysphoria: a placebo‐controlled trial
162 Citations1992Charlotta Sundblad, Kjell Modigh +2 more
It is concluded that low doses of clomipramine effectively reduce premenstrual irritability and dysphoria with a response rate close to 100%.
The Journal of Clinical Endocrinology & MetabolismSuccessful Treatment of Severe Premenstrual Syndrome by Combined Use of Gonadotropin-Releasing Hormone Agonist and Estrogen/Progestin*
159 Citations1991Joseph F. Mortola, L. GIRTON +1 more
Administration of GnRH-a alone resulted in a 75% improvement in luteal phass symptom scores and the effects of estrogen/progestin replacement on the symptomatic improvement afforded by Gn RH-a were evaluated in eight women with severe PMS.
PubMedTreatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
156 Citations1992Samuel H. Wood, Joseph F. Mortola +3 more
Fluoxetine appears to be a highly effective, well-tolerated treatment for the psychological and physical symptoms accompanying severe PMS.
American Journal of Obstetrics and GynecologyLasting response to ovariectomy in severe intractable premenstrual syndrome
149 Citations1990Peter R. Casson, Philip M. Hahn +2 more
It is concluded that cyclic ovarian steroidogenesis is a powerful determinant for the expression of pre menstrual symptomatology and Ovariectomy with low-dose estrogen replacement is an effective alternative for the woman with debilitating premenstrual syndrome who does not respond to conventional interventions.
Journal of Affective DisordersDepression and weight gain: the serotonin connection
148 Citations1993Judith J. Wurtman
The inability to control food intake and to engage in consistent exercise may account for repetitive episodes of weight gain, and prevention may require periodic or sustained interventions that maintain mood and control over food intake.
Journal of Affective DisordersPrevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder
144 Citations1990Teri Pearlstein, Ellen Frank +4 more
The authors interviewed 78 female patients with late luteal phase dysphoric disorder and found a 78% lifetime prevalence of axis I disorders but only a 10% prevalence ofaxis II disorders.
American Journal of Obstetrics and GynecologyThe effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome
134 Citations1990Robert F. Casper, Margaret T. Hearn
Surgical therapy, involving oophorectomy, hysterectomy and continuous estrogen replacement, is effective in relieving the symptoms of premenstrual syndrome and is indicated for a small, selected group of women.
PubMedFluoxetine in the treatment of late luteal phase dysphoric disorder.
132 Citations1991Andrea B. Stone, T B Pearlstein +1 more
Fluoxetine is an effective and well-tolerated treatment for late luteal phase dysphoric disorder and symptoms decreased significantly in all 10 LLPDD diagnostic categories in the fluoxetines treated group.
PubMedEpidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior.
129 Citations1988Susan R. Johnson, Cheyenne McChesney +1 more
The findings support the conclusion that premenstrual symptoms are common but do not usually interfere with functioning.
Journal of Affective DisordersThe menstrual cycle and mood disorders
120 Citations1993Jane Endicott
It is revealed that, at least for a subset of women with mood disorders, the premenstrual phase of the cycle may be aperiod of increased vulnerability for the appearance of a period of severe depression or for the worsening of an ongoing period of depression.
American Journal of PsychiatryLate luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints
110 Citations1992Stephen W. Hurt, Paula P. Schnurr +5 more
The variability in the frequency of LLPDD diagnosis according to method of assessing symptom change underscores the need for a uniform assessment method.
The British Journal of PsychiatryThe Premenstrual Syndrome: A Twin Study
105 Citations1993John T. Condon
The results of a self-report questionnaire on the premenstrual syndrome are consistent with the hypothesis that aggregation for global PMS scores is determined by genetic factors acting additively over a number of loci.
Archives of General PsychiatryThe Emergence of Suicidal Ideation and Behavior During Antidepressant Pharmacotherapy
104 Citations1991J. John Mann
The biologic aspects of suicidal behavior are reviewed, with special reference to the role of serotonin (5-HT) and to the evidence for the emergence of paradoxical suicidality during antidepressant treatment.
Archives of General PsychiatryTreatment of Premenstrual Dysphoria With Alprazolam
103 Citations1990Wilma Harrison
Improved study design, which addressed methodologic flaws of most previous studies of treatment outcome of "premenstrual syndrome" may account, in part, for the ability to demonstrate significant drug/placebo differences.
BMJFluoxetine treatment of severe premenstrual syndrome.
98 Citations1992David B Menkes, E. Taghavi +3 more
Calculation of the numbers of cancers that might be initiated if intramuscular vitamin K is causally related and if no one received any vitamin K 980 cancers would occur.
PubMedSevere premenstrual tension: delineation of the syndrome.
92 Citations1980Haskett Rf, M. Steiner +2 more
Existing scales for depression, anxiety, and hostility did not demonstrate that the core disturbance of PMTS is any of these dimensions alone, and item analysis of the MDQ revealed that irritability, mood lability, tension, and restlessness were the most prominent emotional descriptors of this specific syndrome.
Gynecologic and Obstetric InvestigationImipramine Receptor Binding and Serotonin Uptake in Platelets of Women with Premenstrual Changes
88 Citations2010Nathan Rojansky, Uriel Halbreich +3 more
Clinical Obstetrics & GynecologyFemale-Specific Mood Disorders
85 Citations1992Meir Steiner
It is plausible to assume that women with LLPDD are vulnerable to the menstrual cycle as a Zeitgeber, and future epidemiologic studies on depression should consider the effects of female-specific Zeitgebers on mood disorders in the populations studied.
Archives of General PsychiatryAlprazolam in the Treatment of Premenstrual Syndrome
82 Citations1993Peter J. Schmidt
The findings do not support alprazolam as a uniformly effective treatment for the symptoms of premenstrual syndrome.
International Clinical PsychopharmacologyFluoxetineʼs spectrum of action in premenstrual syndrome
66 Citations1993David B Menkes, E. Taghavi +2 more
Fluoxetine's efficacy extended over a range of affective, physical and behavioural symptoms; its superiority obtained whether it preceded or followed placebo; and the relationship between steady-state drug level and clinical outcome was assessed.
PubMedFluoxetine in the treatment of premenstrual syndrome.
55 Citations1990Stone Ab, Pearlstein Tb +1 more
Preliminary results suggest that fluoxetine is an effective and well-tolerated treatment for severe PMS.
Acta Psychiatrica ScandinavicaEffect of clomipramine on premenstrual syndrome
54 Citations1990Elias Eriksson, Pia Lisjö +4 more
Clomipramine (25–50 mg) was administered daily for 5 consecutive menstrual cycles to 5 nondepressed women with severe premenstrual irritability and sadness and all subjects reported a dramatic reduction in premen menstruation complaints.
PubMedAlprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study.
51 Citations1994Charlene Berger, B Presser
Alprazolam is efficacious in the treatment of two groups of patients diagnosed with late luteal phase dysphoric disorder and mild symptoms of anxiety and depression during the follicular phase.
PsychopharmacologyFluvoxamine in the treatment of menstrually related mood disorders
47 Citations1990Arend T. Veeninga, H.G.M. Westenberg +1 more
The results of this study do not support a role for serotonin in menstrually related affective symptoms, and fluvoxamine was found to be not different from placebo.
American Journal of Obstetrics and GynecologyPremenstrual syndrome: Documentation by a linear analog scale compared with two descriptive scales
46 Citations1986Robert F. Casper, Anne-Marie Powell
The results suggest that the linear analog scale may be a useful clinical tool in the study of premenstrual syndrome and that its sensitivity to detect changes in symptom severity throughout the menstrual cycle may prove useful in evaluating the effects of therapy for premen menstruation syndrome.
The Canadian Journal of PsychiatryIs 5HT <sub>1A</sub> Receptor Subsensitivity a Trait Marker for Late Luteal Phase Dysphoric Disorder? A Pilot Study
42 Citations1993Lakshmi N. Yatham
Prolactin responses to buspirone challenges were examined in women with late luteal phase dysphoric disorder and the same number of healthy controls and the responses were found to be blunted during the follicular phase suggesting that 5-HT1A receptor subsensitivity is perhaps a trait rather than a state marker for LLPDD.
Life SciencesThe treatment of late luteal phase dysphoric disorder
14 Citations1991Susanne Steinberg
The availability of an operational definition of LLPDD in the DSM-III-R and the improvement in research methodology has provided a clearer direction for clinical management and for future investigations.
Biological PsychiatryFollicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder
13 Citations1994Donna E. Stewart, Margaret Fairman +3 more
The Canadian Journal of PsychiatryProblems in the Treatment of Premenstrual Syndrome
12 Citations1990Gail Erlick Robinson, Paul E. Garfinkel
The most effective current management of PMS is a conservative one including accurate diagnosis, stress control, sensible levels of diet and exercise and perhaps the use of alprazolam in the premenstrual period.
American Journal of PsychiatryCourse of premenstrual syndrome symptom severity after treatment
6 Citations1992E W Freeman, Karl Rickels +1 more
Patients from a randomized, double-blind, placebo-controlled study of progesterone suppository treatment for premenstrual syndrome (PMS) were followed up to determine poststudy PMS symptom levels and medication use.